These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19538596)

  • 1. Partial agonists and schizophrenia: theoretical developments for the development of mental health nursing.
    Jones M; White J; Gray R
    J Psychiatr Ment Health Nurs; 2009 Jun; 16(5):409-15. PubMed ID: 19538596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embodiment of severe and enduring mental illness: finding meaning in schizophrenia.
    McCann TV; Clark E
    Issues Ment Health Nurs; 2004 Dec; 25(8):783-98. PubMed ID: 15545243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New facts on schizophrenia.
    Gournay K
    Nurs Times; 1995 Jun 21-7; 91(25):32-3. PubMed ID: 7630754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurobiology and treatment of mentalisation in schizophrenia].
    Herold R; Tényi T
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):187-93. PubMed ID: 16496483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication.
    Jones M; Jones A
    J Psychiatr Ment Health Nurs; 2007 Jun; 14(4):418-23. PubMed ID: 17517033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
    Kilian R; Dietrich S; Toumi M; Angermeyer MC
    Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an outcomes-oriented approach for the treatment of schizophrenia.
    Lehman AF
    J Clin Psychiatry; 1999; 60 Suppl 19():30-5; discussion 36-7. PubMed ID: 10507278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older people with chronic schizophrenia.
    Karim S; Overshott R; Burns A
    Aging Ment Health; 2005 Jul; 9(4):315-24. PubMed ID: 16019287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
    Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
    J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia: into the next millennium.
    Jones B
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S67-9. PubMed ID: 7902776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of the use of research tools in evaluating quality of life for people with schizophrenia.
    Hewitt J
    Int J Ment Health Nurs; 2007 Feb; 16(1):2-14. PubMed ID: 17229269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.
    Weiss EM; Bilder RM; Fleischhacker WW
    Psychopharmacology (Berl); 2002 Jun; 162(1):11-7. PubMed ID: 12107611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of training in psychosocial intervention.
    Bradshaw T; Everitt J
    Nurs Times; 1999 Mar 24-30; 95(12):48-9. PubMed ID: 10232245
    [No Abstract]   [Full Text] [Related]  

  • 16. The concepts of remission and recovery in schizophrenia.
    Leucht S; Lasser R
    Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The needs of older adults with schizophrenia: implications for psychological interventions.
    Berry K; Barrowclough C
    Clin Psychol Rev; 2009 Feb; 29(1):68-76. PubMed ID: 18973972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication management for people with a diagnosis of schizophrenia.
    Gray R; Robson D; Bressington D
    Nurs Times; 2002 Nov 19-25; 98(47):38-40. PubMed ID: 12494838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
    Burton S
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery as perceived by people with schizophrenia, family members and health professionals: a grounded theory.
    Noiseux S; Ricard N
    Int J Nurs Stud; 2008 Aug; 45(8):1148-62. PubMed ID: 17888440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.